Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
04 2021
Historique:
received: 04 05 2020
revised: 09 10 2020
accepted: 18 10 2020
pubmed: 16 2 2021
medline: 3 8 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

To determine whether women with diminished ovarian reserve (DOR) (quantitatively) had lower rates of euploid blastocysts, as a proxy for oocyte quality. Retrospective cohort study. University reproductive health clinic. A total of 1,152 women aged 19-42 years underwent 1,675 IVF cycles yielding 8,073 blastocysts for biopsy from 2010 to 2019. Preimplantation genetic testing for aneuploidy. Euploid rates, defined as the number of euploid blastocysts divided by the number of biopsied blastocysts per cycle. A total of 225 women (20%) had DOR as infertility diagnosis per the Bologna criteria. Age was higher among the women with DOR (39.5 y vs. 37.0 y). Euploid rates were lower among women with vs. without DOR (29.0% vs. 44.9%). In generalized linear models controlling for age, women with DOR had 24% reduced odds of a biopsied blastocyst being euploid versus women without DOR. In a secondary analysis assigning DOR status to women producing the lowest quartile of age-adjusted mature oocyte yield, this relationship remained. No differences were identified in live birth rates between women with and without DOR after euploid single-embryo transfer independently from age (n = 944 transfers; 56.8% vs. 54.8%, respectively). Blastocysts from women with DOR are less likely to be euploid than those from women without DOR after adjustment for age. Given the concomitant reduction in euploid rates with quantity of oocytes observed in this study, quantitative ovarian reserve assessments (i.e., follicular machinery) may yield insight into relative ovarian aging.

Identifiants

pubmed: 33583594
pii: S0015-0282(20)32623-6
doi: 10.1016/j.fertnstert.2020.10.051
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

966-973

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Eleni Greenwood Jaswa (EG)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California. Electronic address: eleni.jaswa@ucsf.edu.

Charles E McCulloch (CE)

Department of Epidemiology and Biostatistics, University of California, San Francisco, California.

Rhodel Simbulan (R)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California.

Marcelle I Cedars (MI)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California.

Mitchell P Rosen (MP)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH